These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10853886)

  • 41. Drug testing in the workplace.
    Phan HM; Yoshizuka K; Murry DJ; Perry PJ
    Pharmacotherapy; 2012 Jul; 32(7):649-56. PubMed ID: 22605533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The presence of licit and illicit drugs in police stations and their implications for workplace drug testing.
    Doran GS; Deans R; De Filippis C; Kostakis C; Howitt JA
    Forensic Sci Int; 2017 Sep; 278():125-136. PubMed ID: 28715674
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Workplace drug testing.
    Shepardson C
    Ohio Nurses Rev; 2002 Apr; 77(4):7-8. PubMed ID: 15133871
    [No Abstract]   [Full Text] [Related]  

  • 45. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Legal, workplace, and treatment drug testing with alternate biological matrices on a global scale.
    Cone EJ
    Forensic Sci Int; 2001 Sep; 121(1-2):7-15. PubMed ID: 11516881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bioanalysis and Analytical Services Research Group at The Municipal Institute for Medical Research IMIM-Hospital del Mar, Spain.
    Segura J; Pascual JA; Ventura R; Gutiérrez-Gallego R
    Bioanalysis; 2009 Nov; 1(8):1403-9. PubMed ID: 21083089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recommendations for the reliable detection of illicit drugs in urine in the European Union, with special attention to the workplace. EU Toxicology Experts working Group.
    de la Torre R; Segura J; de Zeeuw R; Williams J
    Ann Clin Biochem; 1997 Jul; 34 ( Pt 4)():339-44. PubMed ID: 9247664
    [No Abstract]   [Full Text] [Related]  

  • 49. Alabama laws on drug testing in the work place.
    Morgan WR; Summer GL
    Ala Med; 1995 Nov-1996 Jan; 65(5-7):45-8. PubMed ID: 8607383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primum Non Nocere: A More Proactive Workplace Drug Testing Regime for Australian Medical Practitioners?
    Leyden-Duval C
    J Law Med; 2016; 24(2):398-418. PubMed ID: 30137712
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Workers with alcohol and drug addiction problems. Consensus Document of the Study Group on Hazardous Workers].
    Magnavita N; Bergamaschi A; Chiarotti M; Colombi A; Deidda B; De Lorenzo G; Goggiamani A; Magnavita G; Ricciardi W; Sacco A; Spagnolo AG; Bevilacqua L; Brunati MM; Campanile T; Cappai M; Cicerone M; Ciprani F; Di Giannantonio M; Di Martino G; Fenudi L; Garbarino S; Lopez A; Mammi F; Orsini D; Ranalletta D; Simonazzi S; Stanzani C
    Med Lav; 2008; 99 Suppl 2():3-58. PubMed ID: 19248471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug and alcohol testing in the workplace: moral, ethical and legal issues.
    Raskin C
    Bull Narc; 1993; 45(2):45-81. PubMed ID: 7920542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Physicians' attitudes toward mandatory workplace urine drug testing.
    Lemon SJ; Sienko DG; Alguire PC
    Arch Intern Med; 1992 Nov; 152(11):2238-42. PubMed ID: 1444683
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current practice and experience in drug and alcohol testing in the workplace.
    Zwerling C
    Bull Narc; 1993; 45(2):155-96. PubMed ID: 7920540
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemical dependency and drug testing in the workplace.
    Osterloh JD; Becker CE
    J Psychoactive Drugs; 1990; 22(4):407-17. PubMed ID: 2096185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project.
    Brunt TM; Nagy C; Bücheli A; Martins D; Ugarte M; Beduwe C; Ventura Vilamala M
    Drug Test Anal; 2017 Feb; 9(2):188-198. PubMed ID: 26888408
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A snapshot of workplace drug testing in the UK.
    George S
    Occup Med (Lond); 2005 Jan; 55(1):69-71. PubMed ID: 15699095
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Policing, massive street drug testing and poly-substance use chaos in Georgia - a policy case study.
    Otiashvili D; Tabatadze M; Balanchivadze N; Kirtadze I
    Subst Abuse Treat Prev Policy; 2016 Jan; 11():4. PubMed ID: 26772817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [New psychoactive substances require a paradigm shift in drug testing in Denmark].
    Breindahl T; Hindersson P; Leutscher PD; Kimergård A
    Ugeskr Laeger; 2018 Mar; 180(11):. PubMed ID: 29530235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015.
    Mounteney J; Griffiths P; Sedefov R; Noor A; Vicente J; Simon R
    Addiction; 2016 Jan; 111(1):34-48. PubMed ID: 26419329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.